Most donors and kidney recipients for the exchange of personal health information that may influence success before agreeing on an organ transplant from a living donor, while health professionals are more reluctant according to a study published in an upcoming issue of the Journal of the American Society of Clinical Nephrology (CJASN). The results suggest that physicians should consider supporting and facilitating the exchange of information prior to transplantation.

The living kidney donation is a complex decision with multiple medical, legal and ethical. In many situations it may be difficult to know what personal health information is important to share and what information should remain confidential. For example, knowing that the donor has high blood pressure can affect the willingness of a recipient to accept the gift, or a potential beneficiary who is HIV positive may fear that. Information may change the willingness of donors to make a donation.

(more…)

Like a wayward driver slammed the brakes, a special class of T cells may limit the effectiveness of therapeutic vaccines for HIV by slowing the immune system too soon, the report of the University of Pittsburgh researchers at Health Sciences latest issue of PLoS ONE. Their study, the first to examine the role of regulatory T cells in therapeutic vaccines against HIV, could help researchers improve the effectiveness of these vaccines in the development of methods to prevent the brake mechanism of these cells.

Regulatory T cells (Treg) are essential because they prevent the immune system turns against itself by suppressing the immune response. Without the braking action of Treg, autoimmune disease can thrive. But if these cells are closing the immune response of a therapeutic vaccine had the opportunity to boost immunity against HIV?

(more…)

A novel stem cell therapy arms of the immune system with an intrinsic defense against HIV could be an effective strategy to combat the disease.

Professor Ben Berkhout speech to the Society for Microbiology’s Spring Meeting in Edinburgh, explains how this new approach could substantially improve the quality of life and life expectancy of people living with HIV antiviral drugs that are no more effective .

In the absence of an effective vaccine, daily administration of antiretroviral drugs is the most effective treatment for HIV. However, the low rate of patient compliance with a combined capacity of the virus to mutate easily led to the emergence of antibiotic resistance that are difficult to treat.

Professor Berkhout University of Amsterdam is an investigation of a novel gene therapy that has lasting effects, even after a single treatment. Viral DNA to provide for the patients own immune cells that weapons against viral infection. “This could be an alternative therapy for patients infected with HIV that can be treated with antiviral drugs regularly, he suggested.

(more…)